Previous investigations revealed that the synergistic inhibitory effect of genistein and camptothecin in cervical cancer, ovarian carcinoma and mouse fibroblast cells resulted from their inhibition of NF-κB translocation and the induction of G2/M cell cycle arrest and apoptosis [16]. The gene discussed is NFKB1; the disease is cervical cancer.